Cover Image
市場調查報告書

軟骨肉瘤:全球臨床實驗檢討

Chondrosarcoma Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 297514
出版日期 內容資訊 英文 93 Pages
訂單完成後即時交付
價格
Back to Top
軟骨肉瘤:全球臨床實驗檢討 Chondrosarcoma Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 93 Pages
簡介

本報告提供軟骨肉瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中·南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中軟骨肉瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

E7各國的臨床實驗:腫瘤科臨床實驗中軟骨肉瘤的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與軟骨肉瘤治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Infinity Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Agios Pharmaceuticals, Inc.
    • AEterna Zentaris Inc.
    • ACORN Research, LLC
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Southwest Oncology Group
    • The University of Texas M. D. Anderson Cancer Center
    • Massachusetts General Hospital
    • Memorial Sloan Kettering Cancer Center
    • Radiation Therapy Oncology Group
    • Roswell Park Cancer Institute
    • University of Washington
    • Stanford University

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4282CTIDB

GlobalData's clinical trial report, "Chondrosarcoma Global Clinical Trials Review, H1, 2017" provides an overview of Chondrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chondrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Chondrosarcoma Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profile Snapshots 33

Appendix 91

  • Abbreviations 91
  • Definitions 91
  • Research Methodology 92
  • Secondary Research 92
  • About GlobalData 93
  • Contact Us 93
  • Disclaimer 93
  • Source 93

List of Tables

List of Tables

  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2017* 18
  • Chondrosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Chondrosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

List of Figures

List of Figures

  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2017* 18
  • Chondrosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Chondrosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 92
Back to Top